Dataset Information


A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling.

ABSTRACT: The advent of angiotensin II type 1 receptor blockers (ARBs) as intriguing gastroprotective candidates and the superior pharmacokinetics and pharmacodynamics displayed by irbesartan compared to many other ARBs raised the interest to investigate its gastroprotective potential in a rat model of gastric injury. Irbesartan (50?mg/Kg) was orally administered to male Wistar rats once daily for 14 days; thereafter gastric injury was induced by indomethacin (60?mg/Kg, p.o). Irbesartan reduced gastric ulcer index, gastric acidity, and ameliorated indomethacin-induced gastric mucosal apoptotic and inflammatory aberrations, as demonstrated by hampering caspase-3, prostaglandin E2 and tumor necrosis factor-alpha levels and cyclooxygenase-2 mRNA expression. This ARB increased mucosal dimethylarginine dimethylaminohydrolase-1 (DDAH-1) gene expression and decreased elevated levels of matrix metalloproteinase-9, asymmetric dimethylarginine (ADMA), epidermal growth factor receptor (EGFR) mRNA and phosphorylated extracellular signal-regulated kinase 1 and 2 (pERK1/2). Histopathological evaluation corroborated biochemical findings. Overall efficacy of irbesartan was comparable to ranitidine, the widely used H2 receptor blocker. In conclusion, irbesartan exerts significant gastroprotection against indomethacin-induced mucosal damage via acid-inhibitory, anti-inflammatory, anti-apoptotic and extracellular matrix remodeling mechanisms that are probably mediated, at least partly, by down-regulating DDAH/ADMA and EGFR/ERK1/2 signaling.


PROVIDER: S-EPMC5844881 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2008-01-01 | S-EPMC2439519 | BioStudies
2009-01-01 | S-EPMC2790963 | BioStudies
2016-01-01 | S-EPMC5039408 | BioStudies
2018-01-01 | S-EPMC6087787 | BioStudies
2015-01-01 | S-EPMC4530584 | BioStudies
2012-01-01 | S-EPMC3606823 | BioStudies
1000-01-01 | S-EPMC3271003 | BioStudies
2019-01-01 | S-EPMC6758593 | BioStudies
2013-01-01 | S-EPMC3617194 | BioStudies
2018-01-01 | S-EPMC6288902 | BioStudies